Stimunity

Develops first-in-class drug targeting cGAS and using mRNA technology to stimulate innate immunity. By activating the STING pathway, this approach boosts the immune response against cancers and other pathologies, particularly in patients refractory to conventional treatments. Using virus-like particles (VLPs), this technology stimulates cytokine production and boosts immune cell response.